RESUMO
BACKGROUND: The incidence of postoperative spinal infection (PSI) ranges from 0% to 10%, with devastating effects on the patient prognosis because of higher morbidity while increasing costs to the health care system. PSIs are elusive and difficult to diagnose, especially in the early postoperative state, because of confusing clinical symptoms, rise in serum biomarkers, or imaging studies. Current research on diagnosis has focused on serum biomarkers; nevertheless, most series rely on retrospective cohorts where biomarkers are studied individually and at different time points. OBJECTIVE: This paper presents the protocol for a systematic review that aims to determine the inflammatory biomarker behavior profile of patients following elective degenerative spine surgery and their differences compared to those coursing with PSIs. METHODS: The proposed systematic review will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. This protocol was registered at PROSPERO on January 19, 2022. We will include studies related to biomarkers in adult patients operated on for degenerative spinal diseases and those developing PSIs. The following information will be extracted from the papers: (1) study title; (2) study author; (3) year; (4) evidence level; (5) research type; (6) diagnosis group (elective postoperative degenerative disease or PSI); (7a) region (cervical, thoracic, lumbosacral, and coccygeal); (7b) type of infection by anatomical or radiological site; (8) surgery type (including instrumentation or not); (9) number of cases; (10) mean age or individual age; (11) individual serum biomarker values from the preoperative state up to 90 days postoperative for both groups, including (10a) interleukin-6, (10b) presepsin, (10c) erythrocyte sedimentation rate, (10d) leukocyte count, (10e) neutrophil count, (10f) C-reactive protein, (10g) serum amyloid, (10h) white cell count, (10i) albumin, (10j) prealbumin, (10k) procalcitonin, (10l) retinol-associated protein, and (10m) Dickkopf-1; (11) postoperative days at symptoms or diagnosis; (12) type of organism; (13) day of starting antibiotics; (14) duration of treatment; and (15) any biases (including comorbidities, especially those affecting immunological status). All data on biomarkers will be presented graphically over time. RESULTS: No ethical approval will be required, as this review is based on published data and does not involve interaction with human participants. The search for this systematic review commenced in February 2021, and we expect to publish the findings in mid-2023. CONCLUSIONS: This study will provide the behavior profile of biomarkers for PSI and patients following elective surgery for degenerative spinal diseases from the preoperative period up to 90 days postoperative, providing cutoff values on the day of diagnosis. This research will provide clinicians with highly trustable cutoff reference values for PSI diagnosis. Finally, we expect to provide a basis for future research on biomarkers that help diagnose more accurately and in a timely manner in the early stages of illness, ultimately impacting the patient's physical and mental health, and reducing the disease burden. TRIAL REGISTRATION: PROSPERO CRD42022304645; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=304645. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/41555.
RESUMO
Background: We evaluated in-hospital mortality and outcomes incidence after hospital discharge due to COVID-19 in a Brazilian multicenter cohort. Methods: This prospective multicenter study (RECOVER-SUS, NCT04807699) included COVID-19 patients hospitalized in public tertiary hospitals in Brazil from June 2020 to March 2021. Clinical assessment and blood samples were performed at hospital admission, with post-hospital discharge remote visits. Hospitalized participants were followed-up until March 31, 2021. The outcomes were in-hospital mortality and incidence of rehospitalization or death after hospital discharge. Kaplan-Meier curves and Cox proportional-hazard models were performed. Findings: 1589 participants [54.5% male, age=62 (IQR 50-70) years; BMI=28.4 (IQR,24.9-32.9) Kg/m² and 51.9% with diabetes] were included. A total of 429 individuals [27.0% (95%CI,24.8-29.2)] died during hospitalization (median time 14 (IQR,9-24) days). Older age [vs<40 years; age=60-69 years-aHR=1.89 (95%CI,1.08-3.32); age=70-79 years-aHR=2.52 (95%CI,1.42-4.45); age≥80-aHR=2.90 (95%CI 1.54-5.47)]; noninvasive or mechanical ventilation at admission [vs facial-mask or none; aHR=1.69 (95%CI 1.30-2.19)]; SAPS-III score≥57 [vs<57; aHR=1.47 (95%CI 1.13-1.92)] and SOFA score≥10 [vs <10; aHR=1.51 (95%CI 1.08-2.10)] were independently associated with in-hospital mortality. A total of 65 individuals [6.7% (95%CI 5.3-8.4)] had a rehospitalization or death [rate=323 (95%CI 250-417) per 1000 person-years] in a median time of 52 (range 1-280) days post-hospital discharge. Age ≥ 60 years [vs <60, aHR=2.13 (95%CI 1.15-3.94)] and SAPS-III ≥57 at admission [vs <57, aHR=2.37 (95%CI 1.22-4.59)] were independently associated with rehospitalization or death after hospital discharge. Interpretation: High in-hospital mortality rates due to COVID-19 were observed and elderly people remained at high risk of rehospitalization and death after hospital discharge. Funding: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Programa INOVA-FIOCRUZ.
RESUMO
Abstract The Disease Activity Score 28 (DAS28) shows discrepancies when using erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) scores to assess rheumatoid arthritis (RA). This study aimed to verify the agreement between the DAS28-CRP and DAS28-ESR scores in patients with RA from the south of Brazil. A unicentric cross-sectional study was performed (n = 56). The diagnosis of the patients followed the American College of Rheumatology/ European League Against Rheumatism criteria, and their DAS28 were calculated. The DAS28- ESR score was higher than the DAS28-CRP (DAS28-ESR mean 4.8±1.6; DAS28-CRP mean 4.3±1.4) for 83.9% of the patients. The DAS28-CRP and DAS28-ESR scores showed a very strong correlation (Pearson's coefficient = 0.922; P<0.0001, 95% CI +0.87 to +0.95, statistical power 100%). Spearman's correlation coefficient (0.49; P=0.0001, 95% CI +0.25 to +0.67, statistical power 47.54%) showed a moderate correlation between the unique components of the DAS28 formulas. There was agreement between the tests in only 36 of the patients (64.29%). Among the discordant categories, DAS28-ESR overestimated the classification in 16 patients (28.5%). The Kappa coefficient between the categories was 0.465 (SE 0.084, 95% CI +0.301 to +0.630), showing a moderate degree of agreement between the instruments. Although the DAS28-ESR and DAS28-CRP were highly correlated, they differed significantly in terms of patient categorization and should not be used interchangeably
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Pacientes/classificação , Artrite Reumatoide/patologia , Brasil/etnologia , Indução de Remissão/métodos , Proteína C-Reativa/efeitos adversos , ClassificaçãoRESUMO
OBJECTIVE: Polymyalgia rheumatica (PMR) is the most common inflammatory disease in patients over 50 years. Information about the disease in Latin America (LATAM) is scarce. We aimed to evaluate a group of Colombian patients with PMR and to conduct a systematic review of PMR in LATAM. METHODS: A multicentric retrospective study was performed. Medical records of 256 PMR patients were evaluated. Patients were divided into two groups, those fulfilling the 2012 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for PMR and those who did not (i.e., clinical diagnosis). A systematic literature review and meta regression was performed comparing Colombian vs LATAM patients. RESULTS: From 256 patients, 145 (56.6%) fulfilled the 2012 EULAR/ACR criteria, and 111 (43.3%) were classified by clinical diagnosis. Inflammatory bilateral shoulder pain, pelvic girdle aching, morning stiffness >45 min, elevated erythrocyte sedimentation rate (ESR), and C-reactive protein (CPR), and Methotrexate (MTX) prescription were more common in the 2012 EULAR/ACR group. None of the included patients presented overt polyautoimmunity (PolyA), whereas up to 24% exhibited latent PolyA. In addition, these patients showed high frequency of malignancy (7.59%). In the meta regression analysis, Colombian patients exhibited lower ESR levels, and were less likely to develop giant cell arteritis (GCA) as compared to the rest of LATAM data. CONCLUSION: Patients with PMR in LATAM exhibit similar phenotypes from other cohorts worldwide. Malignancy, GCA and latent PolyA should be considered in the routine clinical follow-up of patients with PMR.
RESUMO
BACKGROUND: PCM is a neglected systemic mycosis endemic in Brazil. The middle-west region of Brazil has shown the highest number of PCM by Paracoccidioides lutzii (P lutzii) cases. Differentiating cases of severe PCM from non-severe ones should be a concern at the bedside. Diagnosis of severe PCM by P lutzii is based on the subjectivity of clinical manifestations, which can result in a delay in starting its treatment and, consequently evolution to severe sequelae. There is not laboratory biomarker available to support the early diagnosis of severe PCM that is feasible for all the realities that coexist in Brazil. OBJECTIVES: The aim of this study was to investigate the usefulness of laboratory biomarkers as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and neutrophil/lymphocyte ratio (NLR) in the diagnosis of severe PCM. PATIENTS/METHODS: ESR, CRP and NLR were analysed for 44 patients with PCM by P lutzii and a Receiver Operation Characteristic (ROC) curve were generated to identify the NLR cut-off point and point out the presence of severe PCM. RESULTS: Sixteen (36.4%) had severe PCM and 28 (63.6%) had non-severe PCM. The mean NLR was higher and statistically significant among patients with severe PCM than among those with non-severe PCM. The area under the ROC curve was 0.859 for the diagnosis of severe PCM. The cut-off point for NLR for the diagnosis of severe PCM was 3.318 (sensitivity of 100%, specificity of 77%). CONCLUSIONS: According to results, it is plausible to conclude that NLR represents a potential biomarker for the diagnosis of severe PCM.
Assuntos
Linfócitos/imunologia , Neutrófilos/imunologia , Paracoccidioides/imunologia , Paracoccidioidomicose/diagnóstico , Paracoccidioidomicose/imunologia , Adulto , Idoso , Infecções Assintomáticas , Biomarcadores/análise , Brasil , Técnicas de Laboratório Clínico , Feminino , Humanos , Contagem de Linfócitos/métodos , Contagem de Linfócitos/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Índice de Gravidade de Doença , Adulto JovemRESUMO
BACKGROUND: Diagnosis of periprosthetic joint infection (PJI) is a multistep process that involves performing various tests including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). The latter two tests, despite being used at all times for PJI diagnosis, are known to be nonspecific and substantially affected by demographic characteristics, including age, gender, race, and body mass index. It is unknown how these variations affect the diagnostic utility of serological markers for PJI. METHODS: Institutional databases were queried to identify patients undergoing revision arthroplasty between 2010 and 2018, in whom preoperative serum ESR and CRP was performed. Patient demographics were collected, and patients were cross-referenced with an internal database to determine their infection status. Analyses were performed to determine how ESR and CRP varied with respect to demographic factors, including age, gender, race, and infection status. Given that patient infection status was known at the time of revision, conclusions were drawn about the effect of these variations in inflammatory markers on the diagnostic utility of ESR and CRP. RESULTS: The value of ESR increased by age was higher in females and African American race. No significant differences were observed in the value of CRP among the demographic factors, although a slight positive trend was observed with respect to age. The variation in inflammatory markers significantly affected the sensitivity, specificity, and accuracy of ESR and CRP for PJI diagnosis. CONCLUSION: Understanding how the accuracy of diagnostic tests varies with respect to demographic factors can help physicians avoid subjecting patients to unnecessary additional testing and reach more accurate diagnoses of PJI.
Assuntos
Artroplastia de Quadril , Artroplastia do Joelho , Infecções Relacionadas à Prótese , Biomarcadores , Sedimentação Sanguínea , Proteína C-Reativa/análise , Demografia , Feminino , Humanos , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/epidemiologia , Infecções Relacionadas à Prótese/cirurgia , Sensibilidade e Especificidade , Líquido Sinovial/químicaRESUMO
Objective: The main purpose of this study was to evaluate serum 25-hydroxyvitamin D (25OHD) levels and its association with in"ammatory markers in patients with rheumatologic diseases (RD). Methods: A cross-sectional study in 154 women with RD (rheumatoid arthritis, spondyloarthritis and other connective tissue diseases) and 112 healthy individuals as a control group (CG) was carried out. Results: No differences in serum and urine calcium, serum phosphate, and urinary deoxypyridinoline were found. RD group had lower 25OHD and higher PTH compared to CG. RD group had higher C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) compared to CG. The overall mean level of 25OHD (ng/ml) was 26.3±12.0 in the CG and 19.4±6.8 in the RD group (p<0.0001). Moreover, CG had lower percentage of individuals with 25OHD de!ciency compared to RD (29.9% vs 53.2%). The femoral neck BMD was signi!cantly lower in postmenopausal RD women compared to CG. 25OHD levels signi!cantly correlated with ESR and CRP as in"ammatory markers. Age, BMI, presence of RD, and CRP were signi!cantly and negatively associated with 25OHD levels through linear regression analysis. According to univariate logistic regression analysis for 25OHD deficiency (<20 ng/ml), a significant and negative association with BMI, presence of RD, ESR and CRP were found. Conclusion: Patients with RD had lower 25OHD levels than controls and the presence of a RD increases by 2.66 the risk of vitamin D de!ciency. In addition, 25OHD has a negative correlation with ESR and CRP as in"ammatory markers. (AU)
Objetivo El objetivo principal de este estudio fue evaluar los niveles séricos de 25-hidroxivitamina D (25OHD) y su asociación con marcadores inflamatorios en enfermedades reumatológicas. Materiales y métodos: Se realizó un estudio transversal en 154 mujeres con enfermedades reumatológicas (artritis reumatoide, espondiloartritis y otras enfermedades del tejido conectivo) y 112 individuos sanos como grupo control (GC). Resultados: No se encontraron diferencias en el calcio sérico y urinario, el fosfato sérico y la desoxipiridinolina urinaria entre el GC y los sujetos con enfermedades reumatológicas. El grupo de pacientes con enfermedades reumatológicas tenía 25OHD más bajo y PTH más alto en comparación con el GC. Asimismo, el grupo de individuos con enfermedades reumatológicas tenía proteína C reactiva (PCR) y velocidad de eritrosedimentación (VES) más altas en comparación con el GC. El nivel de 25OHD (ng/ml) fue 26,3±12,0 en el GC y 19,4±6,8 en el grupo con enfermedades reumatológicas (p<0,0001). Además, el GC presentó un porcentaje menor de deficiencia de 25OHD en comparación con el grupo con enfermedades reumatológicas (29,9% vs 53,2%). La DMO del cuello femoral fue significativamente menor en las mujeres posmenopáusicas con enfermedades reumatológicas en comparación con el GC. La 25OHD correlacionó significativamente con la VES y la PCR como marcadores inflamatorios. El análisis de regresión lineal mostró que la edad, el IMC, la presencia de una enfermedad reumatológica y la PCR se asociaron significativa y negativamente con los niveles de 25OHD. Mientras que el análisis de regresión logística univariada mostró que la deficiencia de 25OHD (<20 ng/ml), se asoció significativa y negativamente con el IMC, la presencia de una enfermedad reumatológica, la VES y los niveles de PCR. Conclusiones: Los pacientes con enfermedades reumatológicas tenían niveles de 25OHD más bajos que los controles y la presencia de una enfermedad reumatológica aumenta en 2.66 el riesgo de deficiencia de vitamina D. Además, la 25OHD mostró correlación negativa con la VES y la PCR como marcadores inflamatorios. (AU)
Assuntos
Humanos , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Vitamina D/análogos & derivados , Vitamina D/sangue , Deficiência de Vitamina D/etiologia , Biomarcadores , Doenças Reumáticas/complicações , Inflamação/sangue , Fosfatos/sangue , Sedimentação Sanguínea , Proteína C-Reativa , Índice de Massa Corporal , Densidade Óssea , Modelos Logísticos , Cálcio/urina , Cálcio/sangue , Doenças Reumáticas/sangue , Risco , Estudos Transversais , Pós-Menopausa , Aminoácidos/urinaRESUMO
Resumen Se evaluó estadísticamente la validez de cuatro métodos para determinar la Velocidad de Eritrosedimentación Globular (VSG) alternos al de Westergren, el que se tomó como "gold standard". Los métodos evaluados fueron Wintrobe (WB), Wintrobe inclinado (WI) a 45° y dos micrométodos capilares, uno vertical (MM) y otro inclinado a 45° (MMI). Se procesaron 419 muestras por los cinco métodos. Se evaluó la concordancia (C), la sensibilidad (S), especificidad (E), valor predictivo positivo (VPP) y valor predictivo negativo (VPN). Los resultados de S, E, VPP, VPN y C fueron: 93,8%, 93,6, 98,8%, 72,8% y 71% en el de WB; 86,3%, 85,7%, 97,2%, 52,4% y 54% en el de WI; 94,6%, 66,6%, 94,1%, 71,4% y 54% para MM y 91,9%, 72,4%, 94,8%, 60,8% y 55% para MMI. El índice kappa mostró una concordancia "buena" entre el método de Westergren y el método de Wintrobe y "moderada" con los métodos de WBI, MM y MMI. Los resultados del presente estudio muestran que el método de Wintrobe es confiable para su uso en el laboratorio clínico comparado con el de Westergreen.
Abstract Four methods were statistically evaluated for their validity to determine the alternative Erythrocyte sedimentation rate to that of Westergren, which was taken as the "gold standard". The methods evaluated were Wintrobe (WB), Wintrobe inclined (WI) at 45° and two capillary micromethods, one vertical (MM) and one inclined at 45° (MMI). A total of 419 samples were processed by the five methods. Concordance (C), sensitivity (S), specificity (E), positive predictive value (PPV) and negative predictive value (NPV) were evaluated. The results for S, E, PPV, NPV and C were: 93.8%, 93.6, 98.8%, 72.8% and 71% for WB; 86.3%, 85.7%, 97.2%, 52.4% and 54% for WI; 94.6%, 66.6%, 94.1%, 71.4% and 54% for MM and 91.9%, 72.4%, 94.8%, 60.8% and 55% for MMI. The kappa index showed "good" agreement between the Westergren method and the Wintrobe method and "moderate" agreement with the WBI, MM and MMI methods. The results of the present study show that the Wintrobe method is reliable for use in the clinical laboratory compared to the Westergren method.
Resumo Neste trabalho, foi avaliada estatisticamente a validez de quatro métodos para determinar a Velocidade de Eritrosedimentação Globular (VSG) alternos ao Westergren, que foi considerado como o "Método Padrão". Os métodos avaliados foram Wintrobe (WB), Wintrobe inclinado a 45° (WI) e dois micro-métodos capilares, um vertical (MM) e outro inclinado a 45° (MMI). 419 amostras foram processadas pelos cinco métodos. Envalou-se a concordância (C), sensibilidade (S), especificidade (E), assim como os valores preditivos positivos (VPP) e negativos (VPN). Os resultados de S, E, VPN e VPP foram: 93.8%, 93.6%, 98.8%, 72.8% e 71% com o WB; 86.3%, 85.7%, 97.2%, 52.4% e 54% com o WI; 94.6%, 66.6%, 94.1%, 71.4% e 54% para MM e 91.9%, 72.4%, 94.8%, 60.8% e 55% para o MMI. O índice kappa apresentou "boa" concordância entre os métodos de Westergren e Wintrobe, enquanto teve concordância "moderada" com os métodos WBI, MMe MMI. Os resultados deste estudo revelaram que o método de Wintrobe é confiável para seu uso no laboratório clínico comparado com o método de Westergren.
RESUMO
Introducción: Para predecir una infección en estadios tempranos en niños con cáncer se han evaluado marcadores como ESD, PCR y PCT. Objetivo: evaluar la precisión diagnóstica para bacteriemia de estos marcadores al ingreso en niños con fiebre y leucemia aguda (LA) o linfoma (L) internados entre 2013-2016. Métodos: estudio analítico retrospectivo. Revisión de historias clínicas. Se calcularon sensibilidad, especificidad, valor predictivo positivo, valor predictivo negativo y área bajo la curva ROC para cada marcador en MedCalc® V16.8.4. Se obtuvo autorización del Comité de Ética. Resultados:en total se internaron 31 niños con diagnóstico de LA y L, 19 presentaron fiebre y 12 no. Hubo 40 episodios de fiebre clasificados en 4 grupos: bacteriemia 14 (35%), infección documentada microbiológicamente 5 (12.5%), infección documentada clínicamente 2 (5%) y fiebre de origen desconocido 19 (47.5%). Los niveles de PCT fueron mayores en el grupo de bacteriemia registrando un valor promedio de 1,17ng/ mL (p: 0.045). El área bajo la curva ROC entre el grupo con y sin bacteriemia fue de 0.50 para ESD, 0.65 para PCR y 0.83 para PCT con S de 77.78%, E de 66.67%, VPP de 50% y VPN de 92.86%. Discusión: la PCT mostró ser el más eficaz que ESD y PCR para predecir bacteriemia. se deben realizar investigaciones con biomarcadores con el objeto de disminuir el uso inadecuado de antibióticos en pacientes con fiebre secundaria a enfermedad y acortar los tiempos de tratamiento en pacientes con infecciones adecuadamente resueltas mejorando ampliamente la calidad de vida en niños con cáncer (AU)
Introduction: To predict infection in early stages in children with cancer, markers such as ESR, CRP, and PCT have been evaluated. Objective: To evaluate the diagnostic precision for bacteremia of these markers on admission of children with fever and acute leukemia (AL) or lymphoma (L) admitted between 2013- 2016. Methods: A retrospective analytical study. Review of the clinical records. Sensitivity, specificity, positive predictive value, negative predictive value, and area under the ROC curve were calculated for each marker in MedCalc® V16.8.4. The study was approved by the Ethics Committee. Results: Overall, 31 children with AL and L were admitted, 19 of whom presented with fever and 12 did not. There were 40 episodes of fever classified into 4 groups: bacteremia 14 (35%), microbiologically documented infection 5 (12.5%), clinically documented infection 2 (5%), and fever of unknown etiology 19 (47.5%). PCT levels were higher in the group with bacteremia with a mean value of 1.17ng/mL (p:0.045). The area under the ROC curve between the groups with and without bacteremia was 0.50 for ESR, 0.65 for CRP, and 0.83 for PCT with a sensitivity of 77.78%, specificity of 66.67%, PPV of 50%, and NPV of 92.86%. Discussion: PCT showed a greater efficacy than ESD and CRP to predict bacteremia. Research on biomarkers should be conducted to reduce the inadequate use of antibiotics in patients with fever secondary to disease and to shorten treatment times in patients with adequately resolved infections, thereby improving quality of life in children with cancer (AU)
Assuntos
Humanos , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Sedimentação Sanguínea , Leucemia/complicações , Reação em Cadeia da Polimerase/métodos , Bacteriemia/diagnóstico , Febre/complicações , Linfoma/complicações , Doença Aguda , Estudos Retrospectivos , Fatores de Risco , Bacteriemia/microbiologiaRESUMO
Introduction Systemic lupus erythematosus is an autoimmune disease with multi-organ involvement. Complications, such as invasive fungal infections usually occur in patients with a greater severity of the disease. Objective The objective of this study was to determine the prevalence and risk variables associated with invasive fungal infections in a Colombian systemic lupus erythematosus population. Materials and methods A cross-sectional, retrospective study that evaluated patients with systemic lupus erythematosus for six years. The primary outcome was invasive fungal infection. Descriptive, group comparison and bivariate analysis was performed using Stata 12.0 software. Results Two hundred patients were included in this study; 84.5% of the patients were women and the median age was 36 years; 68% of the subjects had haematological complications; 53.3% had nephropathy; 45% had pneumopathy and 28% had pericardial impairment; 7.5% of patients had invasive fungal infections and the most frequently isolated fungus was Candida albicans. Pericardial disease, cyclophosphamide use, high disease activity, elevated ESR, C3 hypocomplementemia, anaemia and lymphopenia had a significant association with invasive fungal infection ( P < 0.05). Conclusions We describe for the first time the prevalence of invasive fungal infection in a Colombian population with systemic lupus erythematosus, which was higher than that reported in other latitudes. In this population the increase in disease activity, the presence of pericardial impairment and laboratory alterations (anaemia, lymphopenia, increased ESR and C3 hypocomplementemia) are associated with a greater possibility of invasive fungal infections. Regarding the use of drugs, unlike other studies, in the Colombian population an association was found only with the previous administration of cyclophosphamide. In addition, patients with invasive fungal infections and systemic lupus erythematosus had a higher prevalence of mortality and hospital readmission compared with patients with systemic lupus erythematosus without invasive fungal infection.
Assuntos
Infecções Fúngicas Invasivas/epidemiologia , Lúpus Eritematoso Sistêmico/complicações , Adulto , Estudos Transversais , Feminino , Humanos , Infecções Fúngicas Invasivas/etiologia , Infecções Fúngicas Invasivas/mortalidade , Lúpus Eritematoso Sistêmico/imunologia , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Fatores de RiscoRESUMO
OBJECTIVES: To evaluate serum levels of C-reactive protein and erythrocyte sedimentation rates in patients with untreated newly diagnosed dermatomyositis or polymyositis and their correlation with clinical and laboratory parameters. METHODS: A cross-sectional study including 48 consecutive patients with untreated newly diagnosed dermatomyositis and polymyositis reviewed between 2002 and 2015 was conducted. Fifty healthy subjects were enrolled as controls. RESULTS: Patients with dermatomyositis and polymyositis had higher levels of C-reactive protein and erythrocyte sedimentation rate than healthy controls, but these values were not associated with clinical or laboratory parameters of disease activity either for dermatomyositis or for polymyositis. Additionally, erythrocyte sedimentation rate values correlated with pulmonary involvement as evidenced through computer tomography imaging (OR 1.15; 95%CI 1.01-1.31) only in patients with polymyositis. CONCLUSIONS: Although elevated, C-reactive protein and erythrocyte sedimentation rate are not sensitive parameters for measuring clinical and laboratory activity of dermatomyositis nor for polymiositis. However, erythrocyte sedimentation rate may be a valid parameter for screening pulmonary involvement, particularly in patients with polymyositis.
OBJETIVOS: Avaliar os níveis séricos da proteína C reativa (PCR) e da velocidade de hemossedimentação (VHS) em pacientes recém-diagnosticados com dermatomiosite (DM) e polimiosite (PM), sem tratamento prévio, correlacionando-os com parâmetros clínico-laboratoriais. MÉTODOS: Estudo transversal que incluiu 48 pacientes consecutivos com DM e PM (critérios de Bohan e Peter) recém-diagnosticados, sem tratamento medicamentoso, no período de 2002 a 2015. Foram incluídos 50 indivíduos saudáveis como grupo controle. RESULTADOS: Os pacientes apresentaram níveis mais elevados de VHS e PCR comparativamente aos controles saudáveis. Estes valores, porém, não se correlacionaram com os parâmetros clínicos e laboratoriais da atividade da doença (DM e PM). Somente em pacientes com PM a VHS apresentou relação com acometimento pulmonar na tomografia computadorizada [OR 1,15 (IC 95% 1,01-1,31)]. CONCLUSÕES: Apesar de aumentadas, a PCR e a VHS não são parâmetros sensíveis para a mensuração da atividade clínica e laboratorial de DM e PM., No entanto, a VHS pode ter validade no rastreio do acometimento pulmonar, particularmente em pacientes com PM.
Assuntos
Humanos , Proteína C-Reativa/análise , Polimiosite , Dermatomiosite , Sedimentação Sanguínea , Estudos Transversais , Pneumopatias/etiologiaRESUMO
BACKGROUND: Mycobacterium tuberculosis infection is known to cause inflammation and lung tissue damage in high-risk populations. Nevertheless, direct associations between mycobacterial loads, systemic inflammation and pulmonary lesions upon treatment initiation have not been fully characterized. In the present exploratory study, we prospectively depict the immune profile, microbial clearance and evolution of radiographic lesions in a pulmonary tuberculosis (PTB) patient cohort before and 60 days after anti-tuberculous treatment (ATT) initiation. METHODS: Circulating levels of cytokines (IL-2, IL-4, IL-6, IL-10, IFN-γ, TNF-α) and C-reactive protein (CRP), as well as values of erythrocyte sedimentation rate (ESR) were measured in cryopreserved serum samples obtained from 73 PTB patients at pre-ATT and day 60 of treatment. Changes of the immune profile over time were compared with mycobacterial loads in sputum and culture conversion at day 60 of ATT. Additional analyses tested associations between improvement of chest radiographic lesions at day 60 and pre-treatment status of inflammation and mycobacterial loads. RESULTS: Within the inflammatory parameters evaluated, values of CRP, IL-2, IL-4, TNF-α and ESR significantly decreased upon treatment initiation. On the converse, IL-10 levels substantially increased at day 60 of ATT, whereas concentrations of IL-6 and IFN-γ remained unchanged. Multidimensional analyses revealed that ESR, IL-2, IL-4 and CRP were the parameters with the highest power to discriminate individuals before and after treatment initiation. We further demonstrated that higher bacterial loads in sputum at pre-ATT were associated with increased systemic inflammation and higher risk for positive M. tuberculosis sputum cultures at day 60 of treatment. Furthermore, we found that pre-ATT mycobacterial loads in sputum and systemic inflammation synergistically associated with the status of radiographic lesions during treatment (Relative risk for chest X-ray improvement: 10.0, 95 % confidence interval: 2.4-40.0, P = 0.002). CONCLUSIONS: M. tuberculosis loads in sputum are directly associated to the status of systemic inflammation and potentially impact the immune profile, culture conversion and evolution of lung lesions upon ATT initiation.
Assuntos
Carga Bacteriana , Inflamação/complicações , Escarro/microbiologia , Tuberculose Pulmonar/complicações , Tuberculose Pulmonar/terapia , Adulto , Brasil , Proteína C-Reativa/análise , Estudos de Casos e Controles , Estudos de Coortes , Citocinas/sangue , Feminino , Humanos , Inflamação/sangue , Inflamação/microbiologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Mycobacterium tuberculosis/imunologia , Mycobacterium tuberculosis/isolamento & purificação , Radiografia Torácica , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/microbiologia , Fator de Necrose Tumoral alfa/sangueRESUMO
Introduction: Tuberculosis promotes an acute phase response with an increase of blood reactants, such as C-reactive protein (CRP), among others, which are associated with increased erythrocyte sedimentation rate (ESR). Objective: Evaluate the ESR and the CRP as markers for diagnosis and monitoring cases of pulmonary tuberculosis. Method: Research on patients with clinical, laboratory, and imaging diagnosis of pulmonary tuberculosis, from Itajaí-SC; in which CRP and ESR were analyzed in three different times: at diagnosis, before starting treatment (T0), after three months of treatment (T1), and at the end of treatment (T2). Results: 51 patients were studied at T0 (100%), 43 (84.31%) at T1, and 32 (62.74%) at T2. ESR and CRP values presented significant differences in the three different times (p < 0.0001***). When analyzing the relationship between negative/positive sputum and altered/normal ESR and CRP at T0, ESR (p = 0.0691), CRP (p = 0.0166*). For chest imaging and sputum smear variables it was observed the following: CRP versus smear (p = 0.0002***), ESR versus smear (p = 0.3810), CRP versus chest imaging (p = 0.0097**), and ESR versus chest imaging (p = 0.0766). The correlation between ESR and CRP was: T0 (p = 0.0033**), T1 (p < 0.0001***) and T2 (p = 0.0015**). Conclusion: ESR and CRP proved to be good markers in the diagnosis and monitoring of tuberculosis cases, however, CRP achieve more significant results than ESR. .
Introdução: A tuberculose causa uma resposta de fase aguda com aumento de proteínas sanguíneas, como a proteína C reativa (PCR), entre outras, que estão envolvidas com o aumento da velocidade de hemossedimentação (VHS). Objetivo: Avaliar a VHS e a PCR como marcadores no auxílio diagnóstico e no acompanhamento dos casos de tuberculose pulmonar. Método: Pesquisa realizada com portadores de tuberculose pulmonar com diagnóstico clínico, laboratorial e imaginológico do município de Itajaí-SC, nos quais foram analisadas PCR e VHS em três tempos distintos: no momento do diagnóstico, antes do início do tratamento (T0), aos três meses de tratamento (T1) e ao término do tratamento (T2). Resultados: Foram estudados 51 pacientes em T0 (100%), 43 (84,31%) em T1 e 32 (62,74%) em T2. Os valores de VHS e PCR tiveram diferenças significativas nos três tempos (p < 0,0001***). Quando analisada as relações entre escarro positivo/negativo e VHS e PCR alterado/normal em T0, VHS (p = 0,0691), PCR (p = 0,0166*). Para as variáveis imagem de tórax e baciloscopia, obteve-se: PCR versus baciloscopia (p = 0,0002***); VHS versus baciloscopia (p = 0,3810); PCR versus imagem de tórax (p = 0,0097**); e VHS versus imagem de tórax (p = 0,0766). Correlação entre VHS e PCR: T0 (p = 0,0033**), T1 (p < 0,0001***) e T2 (p = 0,0015**). Conclusão: A VHS e a PCR mostraram-se bons marcadores no auxílio diagnóstico e no acompanhamento dos casos de tuberculose, entretanto, a PCR mostrou resultados mais significativos que a VHS. .
RESUMO
AIM: To determine the influence of non-surgical mechanical periodontal treatment on inflammatory markers related to risk for cardiovascular disease. MATERIAL AND METHODS: A total of 64 patients with severe chronic periodontitis was randomly subjected to immediately periodontal treatment (test group, n = 32) or delayed periodontal treatment, without treatment during the study period (control group, n = 32). Clinical periodontal and laboratory examinations were performed at baseline (T0), 2 months (T2), and 6 months (T6) after the initial examinations (Control group) or completion of periodontal treatment (Test group). RESULTS: After 2 months of periodontal treatment there was a significant reduction of erythrocyte sedimentation rate (ESR) and triglycerides (p = 0.002, p = 0.004, respectively) in the test group. Median values of C-reactive protein, ESR, total cholesterol, and triglycerides were reduced after 6 month of periodontal treatment in the test group (p < 0.001, p < 0.001, p < 0.001, and p = 0.015, respectively). CONCLUSIONS: The non-surgical periodontal treatment was effective in reducing the levels of systemic inflammation markers and improved the lipid profile in subjects with severe chronic periodontitis.
Assuntos
Doenças Cardiovasculares/sangue , Periodontite Crônica/terapia , Desbridamento Periodontal/métodos , Adulto , Biomarcadores/sangue , Sedimentação Sanguínea , Índice de Massa Corporal , Proteína C-Reativa/análise , Colesterol/sangue , Índice de Placa Dentária , Complicações do Diabetes , Escolaridade , Feminino , Seguimentos , Humanos , Hipertensão/complicações , Masculino , Pessoa de Meia-Idade , Perda da Inserção Periodontal/classificação , Perda da Inserção Periodontal/terapia , Índice Periodontal , Bolsa Periodontal/classificação , Bolsa Periodontal/terapia , Fatores de Risco , Fumar , Triglicerídeos/sangueRESUMO
Kikuchi disease is a self-limited disorder of unknown etiology characterized by focal painful lymphadenitis, fever, and weight loss that can be mistaken for malignancy. Diagnosis is established by node biopsy. Kikuchi disease is endemic in Asia; 10 cases have been reported in the US to date. We report 3 cases and review other US cases.
Assuntos
Linfadenite Histiocítica Necrosante/diagnóstico , Linfonodos/patologia , Adolescente , Biópsia , Criança , Connecticut , Diagnóstico Diferencial , Feminino , Humanos , MasculinoRESUMO
OBJECTIVE: To determine the incidence of pathology during routine screening of healthy short children, testing adherence to a consensus statement on the diagnosis and treatment of children with idiopathic short stature, and the cost per identified diagnosis resulting from comprehensive screening. STUDY DESIGN: Retrospective chart review of 1373 consecutive short stature referrals evaluated at the Cincinnati Children's Hospital Medical Center Pediatric Endocrinology Clinic between 2008 and 2011. We identified 235 patients with a height of <3rd percentile, negative history and review of systems, and normal physical examination. Outcome measures were incidence of pathology detection, diagnostic group characteristics, clinicians' adherence to testing guidelines, and screening costs. ANOVA and χ(2) were used to analyze the data. RESULTS: Nearly 99% of patients were diagnosed as possible variants of normal growth: 23% with familial short stature, 41% with constitutional delay of growth and maturation, and 36% with idiopathic short stature. The incidence of newly diagnosed pathology was 1.3%: 1 patient with biopsy-proved celiac disease, 1 with unconfirmed celiac disease, and 1 with potential insulin-like growth factor I receptor defect. On average, each patient had 64.3% of the recommended tests for age and sex; 2.1% of patients had all of the recommended testing. The total screening tests costs were $315321, yielding $105107 per new diagnosis entertained. CONCLUSIONS: Healthy short children do not warrant nondirected, comprehensive screening. Future guidelines for evaluating short stature should include patient-specific testing.
Assuntos
Estatura , Transtornos do Crescimento/diagnóstico , Transtornos do Crescimento/economia , Pediatria/economia , Adolescente , Algoritmos , Biópsia , Criança , Pré-Escolar , Medicina Baseada em Evidências , Feminino , Custos de Cuidados de Saúde , Humanos , Lactente , Masculino , Pediatria/métodos , Estudos RetrospectivosRESUMO
A velocidade de hemossedimentação (VHS) é um exame realizado em laboratórios de análises clínicas há mais de nove décadas. Utilizada na prática médica com poucas indicações precisas, mas auxiliar nas indicações das atividades inflamatórias ou infecciosas e acompanhamento de doenças graves. O exame consiste em colocar sangue humano em uma pipeta de 200 mm, fixar em suporte próprio e esperar uma hora para sedimentação eritrocitária, utilizando como referência a metodologia de Westergren. Entretanto, os laboratórios de análises clínicas, usualmente, utilizam três formas distintas de preparar o exame: diluído com soro fisiológico, diluído com citrato de sódio e sem nenhuma diluição. Este trabalho teve como objetivo comparar o resultado da VHS das três formas de diluição do exame com a mesma amostra de sangue de 104 pacientes. A análise dos resultados de todos os testes hematológicos mostrou aumento estatisticamente significativo do teste, sem diluição em comparação aos testes com diluição em citrato e em solução salina. Esses dados indicam que novos estudos deveriam ser realizados, no sentido de definir realmente qual diluição é a mais correta e ideal e ainda, estabelecer uma nova padronização dos valores de referência para cada diluição, no sentido de facilitar a comparação dos resultados entre os laboratórios e a interpretação dos mesmos pelos médicos.
The erythrocyte sedimentation rate (ESR) is an examination that has been done in clinical laboratories for over nine decades. It is used in medical practice with a little precise indications, but it is auxiliary to indications of inflammatory or infectious activities and monitoring of serious diseases. The test consists of placing human blood in a 200 mm pipette, fix it in a proper support and wait for an hour for erythrocyte sedimentation, using as reference the Westergren method. However, clinical laboratories usually use three different ways of preparing the test: diluted with saline, diluted with sodium citrate and without any dilution. This study aimed to compare the ESR of the three forms of dilution for the exam with the same blood sample from 104 patients. The results of all hematological tests showed a statistically significant increase of the undiluted test compared to the tests with dilution in citrate and saline. These data indicate that new studies should be performed to actually define which dilution is the most correct and most ideal, and also establish new standardized reference values for each dilution in order to facilitate comparison of results among laboratories and the interpretation of test results by doctors.
Assuntos
Sedimentação Sanguínea , Diluição , Ácido CítricoRESUMO
Introducción: la polimialgia reumática (PMR) es una enfermedad inflamatoria que afecta a mayores de 50 años, caracterizada por dolor y rigidez en región cervical, cinturas escapular y pélvica y por una rápida respuesta a los glucocorticoides. Hasta donde sabemos, no hay estudios clínicos sobre PMR en nuestra población. Algunas enfermedades reumatológicas de comienzo tardío como artritis reumatoide (AR), lupus eritematoso sistémico (LES), espondiloartropatías y arteritis de células gigantes (ACG) pueden manifestarse con hallazgos de PMR. Igualmente, neoplasias hematológicas y algunos tumores sólidos pueden presentarse con un síndrome polimiálgico. Objetivo: analizar las características clínicas, de laboratorio y terapéuticas de pacientes de Medellín con PMR entre 1998 y 2011. Métodos: estudio descriptivo transversal. Se revisaron historias clínicas de pacientes con PMR y al menos 1 visita de seguimiento. Se analizaron variables sociales, demográficas, clínicas, de laboratorio y terapéuticas. Resultados: se evaluaron sesenta y nueve pacientes (79,7% mujeres), 68 (98,6%) de los cuales tuvieron dolor y/o rigidez en cintura escapular y 62 (89,8%) en cintura pélvica. La velocidad de sedimentación globular (VSG) fue igual o mayor a 40 mm/h en 43 (62,3%) pacientes y la proteína C reactiva (PCR) igual o mayor a 0,8 mg/dl en 56 (81,2%). El 76.9% de los pacientes recibieron prednisolona en dosis = 15 mg/día; 95,7% respondieron en los 3 primeros meses de tratamiento, 94,2% presentaron remisión (84,6% en los 6 primeros meses) y 39,1% tuvieron recaída (77,8% en el primer año de seguimiento). Los pacientes con VSG elevada tuvieron menor respuesta en el primer mes. Durante el seguimiento, 5 pacientes desarrollaron artritis reumatoide y 2 ACG. Conclusiones: los hallazgos encontrados aportan mayor información sobre las características de los pacientes con PMR en nuestra población y confirman la rápida respuesta al tratamiento con dosis bajas a moderadas de esteroides y menor respuesta inicial en pacientes con VSG elevada. Su diseño y tamaño de muestra son insuficientes para definir asociaciones estadísticamente significativas.
Background: Polymyalgia rheumatic is a syndrome that affects people over 50 years, characterized by pain and stiffness of shoulder and pelvic girdle. Its behavior in our population is unknown. It may be a manifestation of rheumatoid arthritis, systemic lupus erythematous, and neoplasm or could be associated with giant cells arteritis and it is a common indication for steroid usage. Objective: To analyze clinical, laboratory and treatment features of patients with PMR in Medellín between 1998-2011. Methodology: Descriptive cross-sectional study. We reviewed medical records of patients with PMR with at least 1 follow-up visit. We analyzed social, demographic, clinical, laboratory and therapeutic variables. Results: The records of 68 patients were assessed, 79.7% women. Pain and stiffness in shoulder and pelvic girdle were major symptoms. 62.3% had erythrocyte sedimentation rate equal to or greater than 40 mm/h and 81.2% had C reactive protein equal to or greater than 0.8 mg/dl. 76.9% received doses of prednisolone of 15 mg/day or below. 95.7% responded within the first 3 months of treatment, 94.2% showed remission (84.6% within the first 6 months), 39.1% relapsed (most within the first year of monitoring). Those with elevated ESR had a lower response in the first month. Five patients developed rheumatoid arthritis and two patients giant cells arteritis. Conclusions: These findings add more information about the clinical characteristics of patients with PMR. They allow suggesting early responses to treatment with low to moderate doses of steroids and a lower initial response in patients with elevated ESR. Design and sample size are insufficient to identify statistically significant associations.
Assuntos
Humanos , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Polimialgia Reumática , Dor , Neurite do Plexo Braquial , Neoplasias Hematológicas , GlucocorticoidesRESUMO
La respuesta de fase aguda refleja la inflamación tanto aguda como crónica en curso y se presenta en una amplia variedad de condiciones inflamatorias como infecciones, trauma, cirugías, quemaduras, neoplasias, enfermedades reumáticas inflamatorias y ciertas reacciones inmunes a drogas. La velocidad de sedimentación globular (VSG) y la presencia de leucocitosis con desviación a la izquierda son marcadores diagnósticos de enfermedades inflamatorias e infecciosas. Además, la medición de los niveles séricos de las proteínas de fase aguda, particularmente la proteína C reactiva (PCR), es útil en tres situaciones patológicas: infección, inflamación aguda o crónica y en la evaluación del riesgo metabólico. Procalcitonina es un marcador útil de sepsis e infecciones graves. Los niveles elevados de ferritina son característicos de la enfermedad de Still del adulto y el síndrome hemofagocítico, ambos asociados con la inflamación. Aunque los niveles séricos de citoquinas son cruciales para la generación de la inflamación, su utilidad en la clínica está aún bajo investigación. Las concentraciones séricas de los inhibidores de citocinas o receptores solubles de citoquinas, podría aportar información importante para el seguimiento de las enfermedades autoinflamatorias.
The acute phase response reflects of inflammation both acute and ongoing chronic inflammation and occurs in a wide variety of inflammatory conditions such as infections, trauma, surgery, burns, malignancies, inflammatory rheumatic and certain immune reactions drug. The erythrocyte sedimentation rate and leukocytosis with left shift are diagnostic markers for inflammatory and infectious diseases. The levels of acute-phase proteins, especially C-reactive protein, are used to assess both the presence of inflammation and any response to treatment. The measurement of C-reactive protein levels is useful in three types of pathological situation: infection, acute or chronic inflammation, and evaluation of metabolic risk. Procalcitonin is an useful marker of sepsis and severe infection. High levels of ferritin are characteristic of adult-onset Still's disease and hemophagocytic syndrome, both associated with inflammation. Although serum levels of cytokines are crucial for the generation of inflammation, their usefulness in the clinic is still under investigation. Serum concentrations of cytokine inhibitors or soluble cytokine receptors could provide important information for monitoring autoinflammatory diseases.
Assuntos
Humanos , Inflamação , Proteína C , Doenças Reumáticas , Citocinas , Pró-Calcitonina , LeucocitoseRESUMO
A inflamação, localizada ou sistêmica, é uma das características de doenças reumatológicas. A resposta a uma lesão tecidual desencadeia uma série de modificações que promovem eliminação de patógenos, limitação do dano tecidual e restauração da estrutura lesada. Essas modificações dependem do aumento ou da diminuição da concentração sérica de proteínas, conhecidas como biomarcadores inflamatórios, que atuam na resposta inflamatória. A análise laboratorial desses marcadores permite, juntamente com os dados clínicos e outros exames complementares, acessar a atividade de algumas doenças e monitorar a resposta à terapêutica, assim como pode sugerir presença de infecção. Atualmente, o reumatologista tem à sua disposição algumas opções de exames que avaliam a resposta inflamatória, como a proteína C-reativa, a velocidade de hemossedimentação e a eletroforese de proteínas, entre outros. Este artigo revisa as características de alguns desses biomarcadores e o emprego das provas de atividade inflamatória em doenças reumatológicas.
Inflammation is the hallmark of rheumatic diseases. Tissue injury response promotes several modifications, which result in elimination of the offending agent, limitation of tissue damage, and restoration of affected structures. Such modifications depend on the increase or decrease of the serum concentration of certain proteins known as inflammatory biomarkers. Laboratory analysis of these markers assists in monitoring disease activity and treatment response. Rheumatologists have available methods that evaluate inflammatory reaction such as C-reactive protein, erythrocyte sedimentation rate, and protein electrophoresis, among others. In this paper, we review some of those biomarkers and their use in rheumatic diseases.